Insider Screener
Real-time Form 4 Filtering Engine
| Filing Date | Trade Date | Ticker | Company Name | Reporting Person | Relationship | Industry (by SEC) | Type | Price | Qty | Total, $ | Owned After | Change, % |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-03-04 04:42 | 2026-02-27 | ARQT | Arcutis Biotherapeutics Inc. | Matsuda Masaru | Officer; See Remarks | Pharmaceutical Preparations | SALE | $26.03 | 12,058 | $313,877 | 136,932 | -8.1% |
| 2026-02-05 04:35 | 2026-02-02 | ARQT | Arcutis Biotherapeutics Inc. | Matsuda Masaru | Officer; See Remarks | Pharmaceutical Preparations | SALE | $25.28 | 40,638 | $1,027,292 | 110,003 | -27.0% |
| 2025-12-04 01:24 | 2025-12-01 | ARQT | Arcutis Biotherapeutics Inc. | Matsuda Masaru | Officer; See Remarks | Pharmaceutical Preparations | SALE | $30.23 | 1,657 | $50,091 | 150,641 | -1.1% |
| 2025-11-22 02:34 | 2025-11-19 | ARQT | Arcutis Biotherapeutics Inc. | Matsuda Masaru | Officer; See Remarks | Pharmaceutical Preparations | SALE | $28.29 | 2,550 | $72,135 | 151,476 | -1.7% |
| 2025-11-06 02:23 | 2025-11-03 | ARQT | Arcutis Biotherapeutics Inc. | Matsuda Masaru | Officer; See Remarks | Pharmaceutical Preparations | SALE | $24.72 | 7,208 | $178,156 | 154,026 | -4.5% |
| 2025-09-09 00:14 | 2025-09-04 | ARQT | Arcutis Biotherapeutics Inc. | Matsuda Masaru | Officer; See Remarks | Pharmaceutical Preparations | SALE | $16.16 | 36,130 | $583,716 | 161,234 | -18.3% |
| 2025-08-06 01:28 | 2025-08-04 | ARQT | Arcutis Biotherapeutics Inc. | Matsuda Masaru | Officer; See Remarks | Pharmaceutical Preparations | SALE | $14.33 | 6,330 | $90,687 | 197,364 | -3.1% |
| 2025-05-30 03:25 | 2025-05-28 | ARQT | Arcutis Biotherapeutics Inc. | Matsuda Masaru | Officer; See Remarks | Pharmaceutical Preparations | SALE | $13.78 | 1,800 | $24,807 | 202,599 | -0.9% |
| 2025-05-06 00:20 | 2025-05-02 | ARQT | Arcutis Biotherapeutics Inc. | Matsuda Masaru | Officer; See Remarks | Pharmaceutical Preparations | SALE | $15.20 | 5,030 | $76,453 | 204,399 | -2.4% |
| 2025-03-05 03:43 | 2025-03-03 | ARQT | Arcutis Biotherapeutics Inc. | Matsuda Masaru | Officer; See Remarks | Pharmaceutical Preparations | SALE | $13.03 | 3,263 | $42,520 | 209,429 | -1.5% |
| 2025-02-05 04:01 | 2025-02-03 | ARQT | Arcutis Biotherapeutics Inc. | Matsuda Masaru | Officer; See Remarks | Pharmaceutical Preparations | SALE | $12.70 | 8,338 | $105,893 | 178,692 | -4.5% |
| 2024-12-04 00:16 | 2024-05-31 | ARQT | Arcutis Biotherapeutics Inc. | Matsuda Masaru | Officer; See Remarks | Pharmaceutical Preparations | BUY | $3.28 | 5,657 | $18,543 | 187,030 | +3.1% |
| 2024-11-20 03:52 | 2024-11-19 | ARQT | Arcutis Biotherapeutics Inc. | Matsuda Masaru | Officer; See Remarks | Pharmaceutical Preparations | SALE | $9.68 | 1,775 | $17,190 | 181,373 | -1.0% |
| 2024-11-06 00:46 | 2024-11-04 | ARQT | Arcutis Biotherapeutics Inc. | Matsuda Masaru | Officer; See Remarks | Pharmaceutical Preparations | SALE | $8.68 | 5,015 | $43,551 | 178,273 | -2.7% |
| 2024-08-05 23:37 | 2024-08-02 | ARQT | Arcutis Biotherapeutics Inc. | Matsuda Masaru | Officer; See Remarks | Pharmaceutical Preparations | SALE | $9.02 | 5,220 | $47,064 | 183,288 | -2.8% |
| 2024-05-30 02:38 | 2024-05-28 | ARQT | Arcutis Biotherapeutics Inc. | Matsuda Masaru | Officer; See Remark | Pharmaceutical Preparations | SALE | $9.01 | 1,775 | $15,988 | 188,508 | -0.9% |
| 2024-05-03 23:22 | 2024-05-02 | ARQT | Arcutis Biotherapeutics Inc. | Matsuda Masaru | Officer; See Remark | Pharmaceutical Preparations | SALE | $8.74 | 5,016 | $43,829 | 185,408 | -2.6% |
| 2024-03-07 01:14 | 2024-03-04 | ARQT | Arcutis Biotherapeutics Inc. | Matsuda Masaru | Officer; See Remark | Pharmaceutical Preparations | SALE | $11.12 | 3,760 | $41,816 | 190,424 | -1.9% |
| 2023-11-22 01:47 | 2023-11-21 | ARQT | Arcutis Biotherapeutics Inc. | Matsuda Masaru | Officer; See Remark | Pharmaceutical Preparations | SALE | $1.98 | 1,850 | $3,661 | 46,634 | -3.8% |
| 2023-06-03 03:31 | 2023-05-31 | ARQT | Arcutis Biotherapeutics Inc. | Matsuda Masaru | Officer; See Remark | Pharmaceutical Preparations | SALE | $7.80 | 1,830 | $14,278 | 42,146 | -4.2% |
| 2023-03-07 02:52 | 2023-03-02 | ARQT | Arcutis Biotherapeutics Inc. | Matsuda Masaru | Officer; See Remarks | Pharmaceutical Preparations | SALE | $15.83 | 1,434 | $22,696 | 18,101 | -7.3% |
| 2022-11-23 03:06 | 2022-11-21 | ARQT | Arcutis Biotherapeutics Inc. | Matsuda Masaru | Officer; See Remark | Pharmaceutical Preparations | SALE | $18.19 | 1,720 | $31,289 | 19,535 | -8.1% |
| 2022-06-02 23:48 | 2022-06-02 | ARQT | Arcutis Biotherapeutics Inc. | Matsuda Masaru | Officer; SVP and General Counsel | Pharmaceutical Preparations | SALE | $19.73 | 1,795 | $35,419 | 16,380 | -9.9% |
Strategic Signal Filtering
Our screener allows you to cut through the noise of routine stock grants and small trades. By focusing on high-value transactions from C-suite executives (CEO/CFO), you can identify where the "Smart Money" is being deployed with maximum conviction.
Investing Without Illusions
Insider data is not a magic wand, but it is the most honest indicator available. While insiders sell for many reasons (taxes, personal needs), they generally buy for only one: they believe the stock price is undervalued. We provide the tools to track these skin-in-the-game moves.
UNDERSTANDING THE DATA
FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.
TRADE DATE: The actual day the insider executed the purchase or sale in the market.
INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.
OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.
CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.
TRADE TYPES DEFINITIONS
BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.
SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.
OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.